MeSH tree: C01.221.812
Over two decades, medical care improvements have increased health spans in the U.S. by 1.3 years and medical spending by $234,000 per person over their lifetime—or about $182,000 per additional healthy year of life gained—when ...
Feb 28, 2026
0
10
Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral antiretroviral therapy (ART) in persons with human immunodeficiency virus (HIV) and medication adherence challenges, according to a ...
Feb 27, 2026
0
17
Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing the acquisition of gonorrhea, according to the results of the world's largest randomized control trial ...
Feb 25, 2026
0
7
Patients with thyroid eye disease (TED) have a higher prevalence of low-risk human papillomavirus (HPV) diagnosed before autoimmune hyperthyroidism onset than matched controls, according to a research letter published online ...
Feb 25, 2026
0
7
A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could effectively replace more complicated HIV treatment regimens used by people living with HIV who are ...
Feb 25, 2026
0
24
Cervical cancer rates are plummeting in states with higher rates of HPV vaccination, a new study reports. Overall, cervical cancers have declined by 27% among young women in the years since the human papillomavirus (HPV) ...
Feb 24, 2026
0
8
By pairing digital tools with tailored HIV services delivered by community health workers and clinicians, a study has reduced new HIV cases by 70% in rural Kenya and Uganda. This successful strategic implementation of existing ...
Feb 24, 2026
0
21
As new infectious threats emerge worldwide, a key U.S. health agency is quietly stepping away from language tied to pandemic planning, a change some experts warn could leave Americans less protected when the next crisis hits.
Feb 18, 2026
0
5
Kenya will roll out a groundbreaking new HIV-prevention drug in March across 15 priority regions, the health ministry said on Wednesday.
Feb 18, 2026
0
11
Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting the gp120 on the viral ...
Feb 17, 2026
0
20
